-
CED-ähnliche Symptomatik bei einem Jungen mit Adenosindesaminase-2-Mangel (DADA-2)
Rack, K., Minichmayr, E., Lanzersdorfer, R. & Högler, W., 20 Aug 2025, In: Monatsschrift Kinderheilkunde. S 2, p. 120 P03-05.Research output: Contribution to journal › Poster Abstract › peer-review
-
Citrullinämie Typ 2 als seltene Ursache einer neonatalen Cholestase: Ein Fallbericht
Mohamed, I., Lanzersdorfer, R., Minichmayr, E., Rack, K. & Högler, W., 20 Aug 2025, In: Monatsschrift Kinderheilkunde. S 2, p. 122 P03-09.Research output: Contribution to journal › Poster Abstract › peer-review
-
Trientin als Erstlinientherapie bei M. Wilson: eine Single Center Experience
Mohamed, I., Minichmayr, E., Lanzersdorfer, R. & Högler, W., 20 Aug 2025, In: Monatsschrift Kinderheilkunde. S 2, p. 122 P03-11.Research output: Contribution to journal › Poster Abstract › peer-review
-
The influence of liver transplantation on the interplay between gut microbiome and bile acid homeostasis in children with biliary atresia
Waldner, B., Aldrian, D., Zöggeler, T., Oberacher, H., Oberhuber, R., Schneeberger, S., Messner, F., Schneider, A., Kohlmaier, B., Lanzersdorfer, R., Huber, W., Entenmann, A., Müller, T. & Vogel, G. F., Jun 2023, In: Hepatology Communications. 7, 6, 14 p., e0151.Research output: Contribution to journal › Article › peer-review
Open Access -
Fäkaler Mikrobiota Transfer (FMT) bei Kindern und Jugendlichen - Review und Stellungnahme der GPGE AG Mikrobiom
Translated title of the contribution :Fecal Microbiota Transfer (FMT) in Children and Adolescents - Review and statement by the GPGE microbiome working group Research output: Contribution to journal › Review article › peer-review
-
Prospektive nicht-interventionelle multizentrische Studie zur Evaluierung der Wirkspiegel-konzentrationen von Biologikatherapien bei chronisch entzündlichen Darmerkrankungen im Kindes- und Jugendalter
Minichmayr, E. (Researcher), Lanzersdorfer, R. (Researcher), Rack, K. (Researcher) & Mohamed, I. (Researcher)
19.12.2024 → 18.12.2028
Project: Clinical studies › Clinical Study (Academic - no third-party funds)
-
An 18-month, open-label, single-arm safety extension study of an age-and bodyweightadjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children and young adults from 1 to 18 years of age with chronic kidney disease and proteinuria
Lanzersdorfer, R. (PI)
10.01.2023 → 30.06.2028
Project: Clinical studies › Clinical Study (Industry project)
-
NEOCYST - Network for Early Onset Cystic Kidney Diseases
Högler, W. (PI) & Lanzersdorfer, R. (PI)
01.08.2020 → 30.06.2030
Project: Other › Project from scientific scope of research unit
-
A 6-month multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and PK/PD of an age-and body weight-adjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children, 6 months to <18 years of age, with
Grünberger, J. (Researcher), Wagner, N. (Researcher) & Lanzersdorfer, R. (PI)
07.04.2023 → 01.01.2026
Project: Clinical studies › Clinical Study (Industry project)
-
An 18-month, open-label, single-arm safety extension study of an age-and bodyweightadjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children and young adults from 1 to 18 years of age with chronic kidney disease and proteinuria
Grünberger, J. (Researcher) & Lanzersdorfer, R. (PI)
30.01.2023 → 01.01.2026
Project: Clinical studies › Clinical Study (Industry project)
Activities
- 1 Poster presentation
-
Citrullinämie Typ 2 als seltene Ursache einer neonatalen Cholestase: ein Fallbericht
Mohamed, I. (Speaker), Lanzersdorfer, R. (Speaker), Minichmayr, E. (Speaker) & Högler, W. (Speaker)
11 Sept 2025Activity: Talk or presentation › Poster presentation › science-to-science